Literature DB >> 10432012

Development of a high metastatic orthotopic model of human renal cell carcinoma in nude mice: benefits of fragment implantation compared to cell-suspension injection.

Z An1, P Jiang, X Wang, A R Moossa, R M Hoffman.   

Abstract

In this study we compared the metastatic rate of human renal cell carcinoma SN12C in two orthotopic nude mouse models: surgical orthotopic implantation (SOI) of histologically intact tumor tissue and cellular orthotopic injection (COI) of cell suspensions in the kidney. The primary tumors resulting from SOI were larger and much more locally invasive than primary tumors resulting from COI. SOI generated higher metastatic expression than COI. The differences in metastatic rates in the involved organs (lung, liver, and mediastinal lymph nodes) were 2-3 fold higher in SOI compared to COI (P < 0.05). Median survival time in the SOI model was 40 days, which was significantly shorter than that of COI (68 days) (P < 0.001). Histological observation of the primary tumors from the SOI model demonstrated a much richer vascular network than the COI model. Lymph node and lung metastases were larger and more cellular in the SOI model compared to COI. We conclude that the tissue architecture of the implanted tumor tissue in the SOI model plays an important role in the initiation of primary tumor growth, invasion, and distant metastasis. This study directly demonstrates that the implantation of histologically intact tumor tissue orthotopically allows accurate expression of the clinical features of human renal cancer in nude mice. This model should be of value in cancer research and antimetastatic drug discovery for renal cancer, a currently very poorly responding malignancy.

Entities:  

Mesh:

Year:  1999        PMID: 10432012     DOI: 10.1023/a:1006654600095

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  24 in total

1.  Extensive multi-organ metastasis following orthotopic onplantation of histologically-intact human bladder carcinoma tissue in nude mice.

Authors:  X Y Fu; D Theodorescu; R S Kerbel; R M Hoffman
Journal:  Int J Cancer       Date:  1991-12-02       Impact factor: 7.396

2.  Induction of angiogenesis during the transition from hyperplasia to neoplasia.

Authors:  J Folkman; K Watson; D Ingber; D Hanahan
Journal:  Nature       Date:  1989-05-04       Impact factor: 49.962

3.  A new patient-like metastatic model of human lung cancer constructed orthotopically with intact tissue via thoracotomy in immunodeficient mice.

Authors:  X Wang; X Fu; R M Hoffman
Journal:  Int J Cancer       Date:  1992-07-30       Impact factor: 7.396

4.  Influence of organ environment on extracellular matrix degradative activity and metastasis of human colon carcinoma cells.

Authors:  M Nakajima; K Morikawa; A Fabra; C D Bucana; I J Fidler
Journal:  J Natl Cancer Inst       Date:  1990-12-19       Impact factor: 13.506

5.  Surgical orthotopic implantation allows high lung and lymph node metastatic expression of human prostate carcinoma cell line PC-3 in nude mice.

Authors:  Z An; X Wang; J Geller; A R Moossa; R M Hoffman
Journal:  Prostate       Date:  1998-02-15       Impact factor: 4.104

6.  Metastatic human pleural ovarian cancer model constructed by orthotopic implantation of fresh histologically-intact patient carcinoma in nude mice.

Authors:  P Astoul; H G Colt; X Wang; R M Hoffman
Journal:  Anticancer Res       Date:  1993 Nov-Dec       Impact factor: 2.480

7.  Growth and metastasis of tumor cells isolated from a human renal cell carcinoma implanted into different organs of nude mice.

Authors:  S Naito; A C von Eschenbach; R Giavazzi; I J Fidler
Journal:  Cancer Res       Date:  1986-08       Impact factor: 12.701

8.  Nude mouse metastatic models of human stomach cancer constructed using orthotopic implantation of histologically intact tissue.

Authors:  T Furukawa; X Fu; T Kubota; M Watanabe; M Kitajima; R M Hoffman
Journal:  Cancer Res       Date:  1993-03-01       Impact factor: 12.701

9.  Effects of suramin on metastatic ability, proliferation, and production of urokinase-type plasminogen activator and plasminogen activator inhibitor type 2 in human renal cell carcinoma cell line SN12C-PM6.

Authors:  K Marutsuka; Y Hasui; Y Asada; S Naito; Y Osada; A Sumiyoshi
Journal:  Clin Exp Metastasis       Date:  1995-03       Impact factor: 5.150

10.  Characterisation of the vasculature within a murine adenocarcinoma growing in different sites to evaluate the potential of vascular therapies.

Authors:  S E Cowen; M C Bibby; J A Double
Journal:  Acta Oncol       Date:  1995       Impact factor: 4.089

View more
  34 in total

1.  Activity of boanmycin against colorectal cancer.

Authors:  Y C Deng; Y S Zhen; S Zheng; Y C Xue
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

2.  Prostaglandin E2 regulates renal cell carcinoma invasion through the EP4 receptor-Rap GTPase signal transduction pathway.

Authors:  Juanjuan Wu; Yushan Zhang; Nicole Frilot; Jae I Kim; Wan-Ju Kim; Yehia Daaka
Journal:  J Biol Chem       Date:  2011-08-10       Impact factor: 5.157

3.  Is tail vein injection a relevant breast cancer lung metastasis model?

Authors:  Omar M Rashid; Masayuki Nagahashi; Suburamaniam Ramachandran; Catherine I Dumur; Julia C Schaum; Akimitsu Yamada; Tomoyoshi Aoyagi; Sheldon Milstien; Sarah Spiegel; Kazuaki Takabe
Journal:  J Thorac Dis       Date:  2013-08       Impact factor: 2.895

4.  Orthotopic xenografts of RCC retain histological, immunophenotypic and genetic features of tumours in patients.

Authors:  Chiara Grisanzio; Apryle Seeley; Michelle Chang; Michael Collins; Arianna Di Napoli; Su-Chun Cheng; Andrew Percy; Rameen Beroukhim; Sabina Signoretti
Journal:  J Pathol       Date:  2011-06-27       Impact factor: 7.996

5.  Locally Trapping the C-C Chemokine Receptor Type 7 by Gene Delivery Nanoparticle Inhibits Lymphatic Metastasis Prior to Tumor Resection.

Authors:  Sai An; Karthik Tiruthani; Ying Wang; Ligeng Xu; Mengying Hu; Jingjing Li; Wantong Song; Hongnan Jiang; Jirui Sun; Rihe Liu; Leaf Huang
Journal:  Small       Date:  2019-01-28       Impact factor: 13.281

6.  A highly metastatic Lewis lung carcinoma orthotopic green fluorescent protein model.

Authors:  B Rashidi; M Yang; P Jiang; E Baranov; Z An; X Wang; A R Moossa; R M Hoffman
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

7.  Potent anti-tumor effects of EGFR-targeted hybrid peptide on mice bearing liver metastases.

Authors:  Arong Gaowa; Tomohisa Horibe; Masayuki Kohno; Hiroshi Harada; Masahiro Hiraoka; Koji Kawakami
Journal:  Clin Exp Metastasis       Date:  2016-01       Impact factor: 5.150

Review 8.  Patient-derived tumour xenografts as models for oncology drug development.

Authors:  John J Tentler; Aik Choon Tan; Colin D Weekes; Antonio Jimeno; Stephen Leong; Todd M Pitts; John J Arcaroli; Wells A Messersmith; S Gail Eckhardt
Journal:  Nat Rev Clin Oncol       Date:  2012-04-17       Impact factor: 66.675

9.  Detection of disseminated tumor cells in nude mice with human gastric cancer.

Authors:  Bertram Illert; Christoph Otto; Arnulf Thiede; Wolfgang Timmermann
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

Review 10.  Choosing The Right Animal Model for Renal Cancer Research.

Authors:  Paweł Sobczuk; Anna Brodziak; Mohammed Imran Khan; Stuti Chhabra; Michał Fiedorowicz; Marlena Wełniak-Kamińska; Kamil Synoradzki; Ewa Bartnik; Agnieszka Cudnoch-Jędrzejewska; Anna M Czarnecka
Journal:  Transl Oncol       Date:  2020-02-22       Impact factor: 4.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.